Clinical Pharmacy

CP-026

IMPLEMENTATION OF QUALITY PRESCRIBING INDICATORS AND COMPLIANCE BY A RHEUMATOLOGY TEAM

CP-025

EVALUATION OF EFFECTIVENESS OF FAMPRIDINE IN WALKING CAPACITY OF MULTIPLE SCLEROSIS PATIENTS IN A UNIVERSITY HOSPITAL

CP-024

IMPACT OF A MEDICINES REVISION GROUP ON MEDICAL PRESCRIPTION IN A MODERN HOSPITAL

CP-019

HOSPITAL PHARMACISTS’ INTERVENTIONS IN A CENTRAL HOSPITAL

CP-018

CHEMOTHERAPY: A LOT IS STILL UNKNOWN, NEW PERSPECTIVES ON THE INFUSION SEQUENCE

CP-009

ADEQUACY OF INTRAVENOUS IMMUNOGLOBULIN PRESCRIPTION AT A TEACHING HOSPITAL

CP-007

HAEMATOLOGICAL SIDE EFFECTS OF TELAPREVIR-BASED TRIPLE THERAPY IN PATIENTS WITH CHRONIC HEPATITIS C MONOINFECTION

CP-003

CHEMOTHERAPY DOSING AND HAEMATOLOGICAL TOXICITY IN GYNAECOLOGICAL CANCER PATIENTS

Pages